AstraZeneca to launch COPD inhaler Breztri Aerosphere in India this January
The combination medication is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to relieve symptoms and prevent exacerbations in adult patients. Shares of Astrazeneca Pharma India Ltd ended at ₹6,398, down by ₹372.60, or 5.50%, on the BSE.
The combination medication is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to relieve symptoms and prevent exacerbations in adult patients. Shares of Astrazeneca Pharma India Ltd ended at ₹6,398, down by ₹372.60, or 5.50%, on the BSE.
What's Your Reaction?
FEDA-HQ
The Federation of Economic Development Association of India (F.E.D.A) holds the distinction of being India's most venerable umbrella organization. F.E.D.A focused on promoting economic growth in India. Economic development professionals throughout the state, along with individuals and companies in related economic development fields, work together with the F.E.D.A Members and Board of Federation to help positively influence country legislation and industrial growth. With cutting edge policy research and advisory to National and State governments on trade issues. F.E.D.A is one of the leading non-profit organizations with established credentials for enhancing economic development.
